METHOD OF INTEGRATED TREATMENT OF PRIMARY CHRONIC RECURRENT OSTEOMYELITIS IN CHILDREN WITH BACKGROUND SOMATIC STATUS Russian patent published in 2019 - IPC A61B17/56 A61B5/55 A61B6/03 A61L27/24 

Abstract RU 2699742 C1

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to traumatology and orthopedics, and can be used for complex treatment of primary chronic recurrent osteomyelitis in children on a background of somatic status. In preoperative period before radical removal of inflammatory focus is determined by multilayer spiral computed tomography spatial visualization of chronic osteomyelitis affected patient's bone structures. Magnetic resonance tomography is used to assess the extent of their damage, as well as the state of surrounding soft tissues, including the state of their vascular network, which are not visualized when performing multilayer spiral computed tomography. Then, in any sequence, presence or absence of chronic bacterial infection of upper respiratory tract in patient is determined by performing cultures of separated nose and oropharynx on nutrient mediums to detect monocultures and associations of bacteria of genus Staphylococcus, genus Streptococcus and Haemophilus in units of CFU/ml. Patient is diagnosed with the presence or absence of chronic persistent viral herpes infection by the content of specific IgG and IgG antibodies in U/ml in blood for detection of one or association of herpes viruses. Patient is diagnosed with the nature of chronic bacterial and viral infections accompanying somatic diseases of the digestive apparatus with determining the severity of intestinal dysbiosis and excessive bacterial growth of the colonic contents of the patient by sowing feces on nutrient media to detect presence of pathogenic flora in the form of haemolytic E.coli, lactose-negative E.coli and Staphylococcus aureus in CFU/g units. Presence of a secondary immunodeficient state of the patient is detected by the level of IgG, IgM, IgG in IgG and classes IgE in U/ml in blood serum for the severity of the primary chronic multifocal recurrent osteomyelitis. Patient's calcium-calcium metabolism disorders are detected by the level of total calcium, ionised ion and phosphorus in mmol/l, alkaline phosphatase in U/l, parathyroid hormone in pmol/l and vitamin D in ng/ml, as well as content of daily urine calcium and phosphorus in mmol/day. That is followed by the radical removal of the patient's bone structures affected by the primary chronic recurrent osteomyelitis. That is followed by postoperative antibacterial therapy and immunocorrection, in which the presence of pathogenic Staphylococcus bacteria in an amount greater than 104 CFU/ml in the separated nasal and oral pharynx cefuroxime is administered in dose of 15 mg/kg intramuscularly, intravenously or orally every 12 hours for 10-11 days. If observing the presence of Streptococcus pathogenic bacteria in the amount of more than 102 CFU/ml in the separated nose and oropharynx of the patient is prescribed for clindamycin 25 mg/kg/day intramuscularly, intravenously or intravenously divided into 4 doses every 6 hours for 10-11 days. If observing the fact that Haemophilus pathogenic bacteria in the amount of more than 102 CFU/ml are kept in the separated nose and oropharynx of the patient is prescribed cefixime in dose of 4 mg/kg every 12 hours inside for 10-11 days. If observing the presence of specific IgG antibodies and specific IgG antibodies to herpes viruses in amount of 40 U/ml and more in the patient's venous blood, the patient is prescribed valaciclovir 20 mg/kg every 6 hours for 11-12 days. If observing the presence of haemolytic E. coli, lactose-negative E. coli and Staphylococcus aureus in an amount of more than 101 CFU/g is prescribed in pyobacteriofag 20 ml 3 times a day on an empty stomach for 13-14 days. If observing the patient's blood serum content of immunoglobulin of class IgA in amount of less than 0.45 g/l or more than 2.5 g/l, immunoglobulin of class IgM in amount of less than 0.6 g/l or more than 2.5 g/l, immunoglobulin of class Ig G in amount of less than 8 g/l or more than 18 g/l and immunoglobulin of class IgE in amount of more than 100 U/ml Galavit is administered intramuscularly in amount of 5 injections 50–100 mg every other day once a day at night. If observing the content of total calcium in the venous blood of the patient in an amount of less than 2.5 mmol/l, calcium ionized in an amount less than 1.03 mmol/l, phosphorus in an amount less than 0.87 mmol/l, alkaline phosphatase in an amount of less than 40 U/l or more than 150 U/l, parathyroid hormone less than 1.6 pmol/l or more than 6.9 pmol/l and vitamin D less than 30 ng/ml, as well as when determining content in daily urine of calcium patient less than 2.5 mmol/day and phosphorus in amount of less than 12.9 mmol/day prescribed patient receiving alfacalcidol in amount 0.25–0.5 mcg once a day at night for 90–120 days and intake of calcium carbonate in amount of 250–500 mg twice a day after meals in the morning and during lunch for 90–120 days. Cavity formed after radical removal of the inflammatory focus can be filled with "CollapAn" in the form of granules or in the form of "CollapAn"-gel with antibiotic.

EFFECT: method provides postoperative prevention of recurrences with due allowance for etiopathogenetic factors, determination of patient's polymorphism and subsequent conservative treatment taking into account patient's respiratory and digestive system diseases, reliable determination of patient's calcium-calcium metabolism state, as well as bone tissue restoration taking into account the state of calcium-phosphate metabolism of the patient as a result of detecting etiopathogenetic factors of the patient's disease involved in the recurrent chronic osteomyelitis.

1 cl, 3 ex

Similar patents RU2699742C1

Title Year Author Number
AGENT FOR TREATMENT OF PATIENTS WITH IMMUNODEFICINCY STATE 1999
  • Lebedev V.V.
  • Tutel'Jan A.V.
  • Danilina A.V.
  • Shelepova T.M.
  • Stepanov O.G.
  • Zjuzina E.L.
RU2157235C1
METHOD FOR PREVENTING ACUTE RESPIRATORY DISEASES OF THE UPPER RESPIRATORY TRACT IN CHILDREN AT INSULIN-DEPENDENT DIABETES MELLITUS 2005
  • Kostinov Mikhail Petrovich
  • Tarasova Alla Anatol'Evna
RU2294757C1
THERAPY OF RECURRENT STENOSING LARYNGOTRACHEITIS IN CHILDREN 2006
  • Orlova Svetlana Nikolaevna
  • Ryvkin Arkadij Isaakovich
RU2366438C2
AGENT FOR TREATMENT OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSIS 1997
  • Lisitsyna T.A.
  • Durnev A.D.
  • Ivanova M.M.
  • Seredenin S.B.
  • Nasonova V.A.
RU2157684C2
METHOD OF FORECASTING OF RECURRENT COURSE OF LARYNGOTRACHEITIS IN CHILDREN 2008
  • Bashkina Ol'Ga Aleksandrovna
  • Dzhumagaziev Anvar Abdrashitovich
  • Krasilova Anna Vladimirovna
RU2389025C1
METHOD FOR SURGICAL TREATMENT OF PYOINFLAMMATORY PROCESSES OF BONE AND SOFT TISSUE STRUCTURES OF PATIENT'S LOCOMOTOR SYSTEM USING SOFT SPACERS IMPREGNATED WITH ANTIBACTERIAL AGENTS 2019
  • Tsiskarashvili Archil Vazhaevich
  • Melikova Regina Enverpashaevna
RU2729025C1
METHOD OF ACUTE RESPIRATORY DISEASES PREVENTION DURING POSTVACCINAL PERIOD FOR CHILDREN SUFFERING FROM CHRONIC GLOMERULONEPHRITIS AND CHRONIC RENAL INSUFFICIENCY 2005
  • Tarasova Alla Anatol'Evna
  • Kostinov Mikhail Petrovich
  • Lukushkina Elena Fedorovna
  • Volkova Ol'Ga Nikolaevna
RU2325182C2
METHOD FOR DETERMINING INDIVIDUAL SENSITIVITY TO LEVAMYSOL IN CHILDREN SUFFERING FROM NEURODERMITE 1987
  • Grebennikov V.A.
  • Zotova V.V.
  • Simvolokova L.V.
SU1616339A1
BIOPHARMACEUTICAL PREPARATION BASED ON BACILLUS LIVE CULTURE AND METHOD OF INFECTIOUS DISEASE TREATMENT 1998
RU2156134C2
METHOD FOR SURGICAL TREATMENT OF PYOINFLAMMATORY PROCESSES OF BONE AND SOFT TISSUE STRUCTURES OF THE PATIENT'S LOCOMOTOR SYSTEM USING SOFT SPACERS IMPREGNATED WITH AN AMINOGLYCOSIDE AND A GLYCOPEPTIDE 2019
  • Tsiskarashvili Archil Vazhaevich
  • Melikova Regina Enverpashaevna
RU2730838C1

RU 2 699 742 C1

Authors

Ochkurenko Aleksandr Alekseevich

Snetkov Andrej Igorevich

Akinshina Aleksandra Dmitrievna

Simonova Albina Valerevna

Dates

2019-09-09Published

2018-05-21Filed